McDermott + Bull has successfully placed Amani Farid as the Senior Director of Clinical Development at RapidAI. Amani will be responsible for building the corporate development process as well as capturing acquisition and partnership opportunities. She will discover, execute, and integrate new business partnerships and deals critical to the growth of the company.
With a background in legal, Amani brings a tremendous amount of experience in corporate development, having led dozens of transactions throughout her career. In her previous role, she evaluated over 100 opportunities, providing new growth and value to the organization. Her deep understanding of contracts and agreements will greatly benefit RapidAI.
RapidAI is the worldwide leader in advanced imaging for stroke. Installed in over 1,600 hospitals in more than 50 countries, the Rapid imaging platform, powered by artificial intelligence, includes Rapid CTP, Rapid MRI, Rapid CTA, Rapid ICH and Rapid ASPECTS. With their validated, trusted platform, developed by stroke experts, clinicians worldwide are improving patient care and outcomes every day.